Skip to main content

Select Drug Profiles

Payers' Guide, FDA Approvals
Dysport (AbobotulinumtoxinA) Now FDA Approved for the Treatment of Lower-Limb Spasticity in Adults
Lisa A. Raedler, PhD, RPh
Read More
Payers' Guide, FDA Approvals
Dupixent (Dupilumab) First Biologic Drug Approved for Patients with Moderate-to-Severe Atopic Dermatitis
Lisa A. Raedler, PhD, RPh
Read More
Payers' Guide, FDA Approvals
Bavencio (Avelumab) Approved for Metastatic Merkel-Cell Carcinoma and for Urothelial Carcinoma
Lisa A. Raedler, PhD, RPh
Read More
Payers' Guide, FDA Approvals
Zejula (Niraparib) First PARP Inhibitor Approved for Maintenance Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Lisa A. Raedler, PhD, RPh
Read More
Perspectives
A Nurse Navigator’s Perspective on CDK4/6 Inhibitors
Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
Read More
Perspectives
A Payer’s Perspective on CDK4/6 Inhibitors
Kenneth L. Schaecher, MD, FACP, CPC
Read More
Breast Cancer, Oncology
Abemaciclib (Verzenio™), a Novel CDK4/6 Inhibitor, in the Treatment of Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer
Read More
Perspectives
A Pharmacist’s Perspective on CDK4/6 Inhibitors
Robert C. Wolf, PharmD
Read More
Original Research
Newly Diagnosed Hepatitis C in the US Commercially Insured Population Before and After the 2012 Implementation of Expanded Screening Guidelines
Bruce S. Pyenson, FSA, MAAA, Gabriela Dieguez, FSA, MAAA, Christine Ferro, CHFP, Maushumi Mavinkurve, MPH, Yuri Sanchez Gonzalez, PhD
Bruce S. Pyenson, FSA, MAAA; Gabriela Dieguez, FSA, MAAA; Christine Ferro; Maushumi Mavinkurve, MPH; Yuri Sanchez Gonzalez, PhD
Stakeholder Perspective
Importance of Health Outcomes Research for the Treatment of Hepatitis C Infection
Jack E. Fincham, PhD, RPh
by Jack E. Fincham, PhD, RPh
Read More
Original Research, Practice Management
Temporal Trends in Survival and Healthcare Costs in Patients with Multiple Myeloma in the United States
Eric M. Maiese, MHS, PhD, Kristin A. Evans, PhD, Bong-Chul Chu, PhD, Debra E. Irwin, MSPH, PhD
Eric M. Maiese, MHS, PhD; Kristin A. Evans, PhD; Bong-Chul Chu, PhD; Debra E. Irwin, MSPH, PhD
Stakeholder Perspective
Improved Clinical Outcomes with Newer Multiple Myeloma Therapies Associated with Increased Resource Utilization and Financial Burden
Matthew Mitchell, PharmD, MBA, FAMCP
by Matthew Mitchell, PharmD, MBA, FAMCP
Read More
Page 75 of 244
Results 741 - 750 of 2438